RETROSPECTIVE EVALUATION OF THERAPY WITH KETOCONAZOLE IN HORMONE-REFRACTORY PROSTATE CANCER (HRPC)

被引：0
|
作者：
Bonetta, Alberto [1 ]
Derelli, Roberto [1 ]
机构：
[1] Ist Ospitaleri Cremona, Cremona, Italy
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1942 / 1943
页数：2
相关论文
共 50 条
  • [1] Predictive modelling in hormone-refractory prostate cancer (HRPC)
    Bellmunt, Joaquim
    Carles, Joan
    Albanell, Joan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (02): : 82 - 85
  • [2] Predictive modelling in hormone-refractory prostate cancer (HRPC)
    Joaquim Bellmunt
    Joan Carles
    Joan Albanell
    Clinical and Translational Oncology, 2009, 11 : 82 - 85
  • [3] A retrospective analysis on 35 patients with hormone-refractory prostate cancer (HRPC) treated with docetaxel
    Carlini, P.
    Felici, A.
    Ruggeri, E. M.
    Moscetti, L.
    Chilelli, M.
    Ciccarese, M.
    Pino, M. S.
    Cecere, F. L.
    Nuzzo, C.
    Sperduti, I
    Pollera, C. F.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [4] Experience with docetaxel in hormone-refractory prostate cancer (HRPC) at three Australian cancer centers: A retrospective study
    Hovey, Elizabeth
    Gabriel, Gabriel
    George, Monika
    Shapiro, Jeremy
    Chern, Boris
    Moylan, Eugene
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2007, 3 (03) : 156 - 162
  • [5] Vinorelbine (VNB) and estramustine (EMP) in hormone-refractory prostate cancer (HRPC).
    Ferraù, F
    Morgia, G
    Priolo, D
    Vitale, F
    Parisi, A
    Mattina, M
    Calì, S
    ANNALS OF ONCOLOGY, 2000, 11 : 77 - 77
  • [6] Weekly docetaxel for advanced hormone-refractory prostate cancer-HRPC
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [7] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [8] Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients
    Prezioso, Domenico
    Galasso, Raffaele
    Di Martino, Mario
    Iapicca, Gennaro
    Annunziata, Emanuele
    Iacono, Fabrizio
    ANTICANCER RESEARCH, 2007, 27 (02) : 1095 - 1104
  • [9] Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC)
    Papatsoris, AG
    Karamouzis, MV
    Papavassiliou, AG
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (03) : 277 - 296
  • [10] Weekly docetaxel for advanced hormone-refractory prostate cancer-hrpc
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
12345